Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Glimelius

Showing results (391-400 of 416) with videos related to

Pageof 42
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II populationJ F Seligmann, D Morton, F Elliott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2025
Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528]J F Seligmann, D Morton, F Elliott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
p53 mutations in cyclophosphamide-associated bladder cancerM A Khan, L B Travis, C F Lynch, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusionsB Glimelius, J Bergh, L Brandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 29, 2020
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemicC A M Marijnen, F P Peters, C Rödel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescenceC Metayer, C F Lynch, E A Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013D Papamichael, R A Audisio, B Glimelius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2015
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trialF Sclafani, I Chau, D Cunningham, et al.
The Pharmacogenomics Journal|April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysisM M Dias, J-P Pignon, C S Karapetis, et al.
Pageof 42

Showing results (391-400 of 416) with videos related to

Sort By:
Pageof 42
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II populationJ F Seligmann, D Morton, F Elliott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2025
Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528]J F Seligmann, D Morton, F Elliott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
p53 mutations in cyclophosphamide-associated bladder cancerM A Khan, L B Travis, C F Lynch, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusionsB Glimelius, J Bergh, L Brandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 29, 2020
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemicC A M Marijnen, F P Peters, C Rödel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescenceC Metayer, C F Lynch, E A Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013D Papamichael, R A Audisio, B Glimelius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2015
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trialF Sclafani, I Chau, D Cunningham, et al.
The Pharmacogenomics Journal|April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysisM M Dias, J-P Pignon, C S Karapetis, et al.
Pageof 42